Dubovsky Filip 4
4 · NOVAVAX INC · Filed Mar 12, 2024
Insider Transaction Report
Form 4
NOVAVAX INCNVAX
Dubovsky Filip
President, R&D
Transactions
- Exercise/Conversion
Restricted Stock Units
2024-03-10−5,376→ 5,376 total→ Common Stock (5,376 underlying) - Exercise/Conversion
Common Stock
2024-03-10+5,376→ 69,210 total - Tax Payment
Common Stock
2024-03-10$5.45/sh−2,597$14,154→ 66,613 total
Footnotes (2)
- [F1]Each restricted stock unit ("RSU") represents a contingent right to receive one share of Novavax, Inc. (the "Company") common stock.
- [F2]The RSUs subject to this grant under the Company's Amended and Restated 2015 Stock Incentive Plan, as amended, vested or will vest with respect to one-third (1/3) of the RSUs on each of the first three (3) anniversaries of the March 10, 2022 grant date, in each case subject to continued employment through such vesting date